All-trans retinoic acid in combination with α-interferon and dexamethasone for advanced multiple myeloma

Haematologica

Volumn 82, Issue 3, 1997, Pages 354-356

  Musto, Pellegrino ^a   Sajeva, Maria Rosaria ^a   Sanpaolo, Grazia ^a   D'Arena, Giovanni ^a   Scalzulli, Potito Rosario ^a   Carotenuto, Mario ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

All trans retinoic acid; Dexamethasone; Interferon; Interleukin 6; Multiple myeloma

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; RECOMBINANT ALPHA2B INTERFERON; RETINOIC ACID; SOLDESAM F; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE MYELOMA; NAUSEA; ORAL DRUG ADMINISTRATION; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL RESPONSE MODIFIERS; COMBINED MODALITY THERAPY; DEPRESSION; DEXAMETHASONE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PILOT PROJECTS; REMISSION INDUCTION; SALVAGE THERAPY; STOMATITIS; TREATMENT OUTCOME; TRETINOIN;

EID: 0031468423     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sidell N, Taga T, Hirano T, Kishimoto T, Saxon A. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol 1991; 146:3809-14.
2. Ogata A, Nishimoto N, Shima Y, Yoshizaki K, Kishimoto T. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. Blood 1994; 84:3040-6.
3. Palumbo A, Battaglio S, Napoli P, et al. Retinoic acid inhibits the growth of human myeloma cells in vitro. Br J Haematol 1995; 89: 555-60.
4. Siegel D, Niesvizky R, Miller WH Jr, Busquets X, Kurmar R, Michael J. All-trans retinoic acid (ATRA) and Interferon alpha (IFN-α) synergistically inhibit myeloma cell growth and induce retinoic acid receptor-α (RARAα) expression [abstract]. Blood 1992; 80(suppl 1): 121a.
5. Vesole D, Kornbluth J, Jagannath S, et al. Biological response modifiers (BRM) in refractory multiple myeloma (MM): lack of clinical efficacy of recomfainant human interleukin-4 (IL-4) and all-trans retinoic acid (ATRA) [abstract]. Blood 1993; 82(suppl 1):263a.
6. Niesvizky R, Siegel DS, Busquets X, Nichols G, Muindi J. Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma. Br J Haematol 1995; 89:217-8.
7. Musto P, Falcone A, Sajeva MR, D'Arena C, Bonini A, Carotenuto M. All-trans retinoic acid for advanced multiple myeloma [letter]. Blood 1995; 85: 3769-70.
8. Lazzarino M, Corso A, Regazzi MB, Iacona I, Bernasconi C. Modulation of all-trans retinoic acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon therapy. Br J Haematol 1995; 90:928-30.
9. Bollag W. Retinoid and interferon: a new promising combination? Br J Haematol 1991; 79(Suppl 1):87-91.
10. Chen YH, Desai P, Shiao RT, Lavelle D, Hallem A, Chen J. Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites. Blood 1996; 87:314-23.
11. Chen YH, Shiao RT, Labayog JM, Modi S, Lavelle D. Modulation of interleukin-6/interleukin-6 receptor cytokine loop in the treatment of multiple myeloma. Leuk Lymphoma 1997; in press.
12. Adamson P. Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia. Semin Hematol 1994; 31(suppl 5):14-7.